Cargando…

Oncogenic Genetic Alterations in Non-Small-Cell Lung Cancer (NSCLC) in Southwestern China

PURPOSE: To investigate the impact of oncogenic genetic alterations (GAs) on non-small-cell lung cancer (NSCLC) in southwestern China. PATIENTS AND METHODS: We first collected 579 pathologically confirmed NSCLC specimens and then used next-generation sequencing (NGS) to evaluate the DNA samples for...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ma, Yuhui, Li, Quan, Du, Yaxi, Chen, Wanlin, Zhao, Guanqiang, Liu, Xing, Li, Hongsheng, Liu, Junxi, Shen, Zhenghai, Ma, Luyao, Zhou, Yongchun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2020
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7605593/ https://www.ncbi.nlm.nih.gov/pubmed/33149691 http://dx.doi.org/10.2147/CMAR.S266069

Ejemplares similares

Tumor Mutational Burden and PD-L1 Expression in Non-Small-Cell Lung Cancer (NSCLC) in Southwestern China
por: Ma, Yuhui, et al.
Publicado: (2020)

Blood Tumor Mutational Burden as a Predictive Biomarker in Patients With Advanced Non-Small Cell Lung Cancer (NSCLC)
por: Ma, Yuhui, et al.
Publicado: (2021)

Epidermal growth factor receptor T790M mutations in non-small cell lung cancer (NSCLC) of Yunnan in southwestern China
por: Zhou, Yongchun, et al.
Publicado: (2018)

Mutational characteristics of Chinese Han and ethnic minorities in southwestern China: a propensity score matched analysis
por: Zhou, Yongchun, et al.
Publicado: (2022)

Epidermal growth factor receptor (EGFR) mutations in non-small cell lung cancer (NSCLC) of Yunnan in southwestern China
por: Zhou, Yongchun, et al.
Publicado: (2017)

Survival analysis of patients with advanced non-small cell lung cancer receiving EGFR-TKI treatment of Yunnan in southwestern China: a real-world study
por: Lin, Yanping, et al.
Publicado: (2023)

lncRNA DLEU2 modulates cell proliferation and invasion of non-small cell lung cancer by regulating miR-30c-5p/SOX9 axis
por: Zhou, Yongchun, et al.
Publicado: (2019)

MicroRNA‐195 suppresses the progression of lung adenocarcinoma by directly targeting apelin
por: Zhou, Yongchun, et al.
Publicado: (2019)

Unique Profile of Driver Gene Mutations in Patients With Non-Small-Cell Lung Cancer in Qujing City, Yunnan Province, Southwest China
por: Zhou, Yongchun, et al.
Publicado: (2021)

Editorial: Immunotherapy for NSCLC with oncogenic driver variants
por: Du, Yijia, et al.
Publicado: (2022)

Small molecule tyrosine kinase inhibitors modulated blood immune cell counts in patients with oncogene-driven NSCLC
por: Ma, Weijie, et al.
Publicado: (2021)

EVI5 is an oncogene that regulates the proliferation and metastasis of NSCLC cells
por: Cai, Tingting, et al.
Publicado: (2020)

Unique profile on the progress free survival and overall survival in patients with advanced non-small cell lung cancer in the Qujing area, Southwest China
por: Ma, Yuhui, et al.
Publicado: (2023)

TdIF1: a putative oncogene in NSCLC tumor progression
por: Zhang, Yujuan, et al.
Publicado: (2018)

KRAS oncogene may be another target conquered in non‐small cell lung cancer (NSCLC)
por: Chen, Hanxiao, et al.
Publicado: (2020)

circ_0005962 functions as an oncogene to aggravate NSCLC progression
por: Zhang, Zhihong, et al.
Publicado: (2021)

Overcoming MET-mediated resistance in oncogene-driven NSCLC
por: Reischmann, Nadine, et al.
Publicado: (2023)

Linc00996 is a favorable prognostic factor in LUAD: Results from bioinformatics analysis and experimental validation
por: Shen, Zhenghai, et al.
Publicado: (2022)

ESMO20 YO for YO: highlights on oncogene-addicted NSCLC
por: Lim, K.H.J., et al.
Publicado: (2020)

PD-L1 expression and its relationship with oncogenic drivers in non-small cell lung cancer (NSCLC)
por: Jiang, Liyan, et al.
Publicado: (2017)

Molecular Mechanism and Health Role of Functional Ingredients in Blueberry for Chronic Disease in Human Beings
por: Ma, Luyao, et al.
Publicado: (2018)

Lung microbiome alterations in NSCLC patients
por: Zheng, Leliang, et al.
Publicado: (2021)

Ratiometric electrochemical OR gate assay for NSCLC-derived exosomes
por: Meng, Fanyu, et al.
Publicado: (2023)

Choosing the best first-line therapy: NSCLC with no actionable oncogenic driver
por: Kim, So Yeon, et al.
Publicado: (2020)

miR-146a-5p Plays an Oncogenic Role in NSCLC via Suppression of TRAF6
por: Liu, Xiangdong, et al.
Publicado: (2020)

Induction immune-checkpoint inhibitors for resectable oncogene-mutant NSCLC: A multicenter pooled analysis
por: Zhang, Chao, et al.
Publicado: (2022)

Impact of ALK variants on brain metastasis and treatment response in advanced NSCLC patients with oncogenic ALK fusion
por: Qiao, Meng, et al.
Publicado: (2020)

Wolbachia infection in field-collected Aedes aegypti in Yunnan Province, southwestern China
por: Zhang, HengDuan, et al.
Publicado: (2022)

Highway paving in the southwestern Amazon alters long-term trends and drivers of regional vegetation dynamics
por: Klarenberg, G., et al.
Publicado: (2018)

Identification and validation of the methylation biomarkers of non-small cell lung cancer (NSCLC)
por: Guo, Shicheng, et al.
Publicado: (2015)

USP17 is required for trafficking and oncogenic signaling of mutant EGFR in NSCLC cells
por: McCann, Aidan P., et al.
Publicado: (2018)

Role of Radiosurgery and Stereotactic Ablative Radiotherapy for Oligometastatic Non-Oncogene Addicted NSCLC
por: Badellino, Serena, et al.
Publicado: (2022)

Use of liquid biopsy in monitoring therapeutic resistance in EGFR oncogene addicted NSCLC
por: Iacovino, Marialucia, et al.
Publicado: (2020)

Co-occurring genomic alterations and immunotherapy efficacy in NSCLC
por: Zhang, Fan, et al.
Publicado: (2022)

Sarcoidosis‐like reaction after neoadjuvant pembrolizumab combined with chemotherapy mimicking disease progression of NSCLC induced encouraging discovery of pathological complete response
por: Shi, Yuequan, et al.
Publicado: (2021)

Association between oncogenic status and risk of venous thromboembolism in patients with non-small cell lung cancer
por: Dou, Feifei, et al.
Publicado: (2018)

Accurate Classification of Non-small Cell Lung Cancer (NSCLC) Pathology and Mapping of EGFR Mutation Spatial Distribution by Ambient Mass Spectrometry Imaging
por: Zhang, Min, et al.
Publicado: (2019)

ZFP36 loss-mediated BARX1 stabilization promotes malignant phenotypes by transactivating master oncogenes in NSCLC
por: Zhang, Tongjia, et al.
Publicado: (2023)

Protective Effects of Ophiocordyceps lanpingensis on Glycerol-Induced Acute Renal Failure in Mice
por: Zhang, Yanyan, et al.
Publicado: (2017)

HBP1 promoter methylation augments the oncogenic β-catenin to correlate with prognosis in NSCLC
por: Tseng, Ruo-Chia, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_mqe68trast2budan3ufok4il08